4
Changes in Ownership
NEOGENOMICS INC Filed Acc 0001077183-21-000113
Chief Medical Officer acquired 25,050 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Weiss Lawrence Martin · Chief Medical Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-04-22 | Exercise or conversion : show line 1 in the form | +6,667 | $9.22 | $61,470 | 112,464 | D |
| 2021-04-22 | Exercise or conversion : show line 2 in the form | +9,005 | $19.60 | $176,498 | 121,469 | D |
| 2021-04-22 | Exercise or conversion : show line 3 in the form | +9,378 | $28.33 | $265,679 | 130,847 | D |
Table II: Derivative
3 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-04-22 | Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) | −6,667 | $9.22 | 2023-04-19 | 6,667 | 0 | D |
| 2021-04-22 | Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) | −9,005 | $19.60 | 2024-03-01 | 9,005 | 18,012 | D |
| 2021-04-22 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | −9,378 | $28.33 | 2027-03-02 | 9,378 | 28,136 | D |
Loading xslF345X03/wf-form4_161947371579723.xml…